Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Interview With Vantive Latin American North Manager

<< Previous

Bullboard Posts

Next >>

Comment by BlueJays9293on Oct 25, 2024 8:36pm

173 Views

Post# 36282980

RE:RE:Interview With Vantive Latin American North Manager

It's almost like these Vantive executives are giddy at the companies new approach and can't hide their business strategy excitement. They are almost talking like they already own Spectral. Which is weird, cuz' last time I checked, they didn't.

<< Previous

Bullboard Posts

Next >>

Cross border trading in Canada and Australia